Fish oil and glycemic control in diabetes: A meta-analysis

Diabetes Care

Volumn 21, Issue 4, 1998, Pages 494-500

  Friedberg, Cylla E ^a   Janssen, Martien J F M ^c   Heine, Robert J ^b   Grobbee, Diederick E ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Het Rijnland Ziekenhuis

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COD LIVER OIL; DOCOSAHEXAENOIC ACID; ESKISOL; FISH OIL; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PLACEBO; RESQ 1000; SARDINOIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

BLOOD GLUCOSE; CHOLESTEROL, LDL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY FATS, UNSATURATED; FISH OILS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; TRIGLYCERIDES;

EID: 0031897102     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.4.494     Document Type: Article

References (92)

1. Sagild U, Littauer J, Sand Jespersen C, Andersen S: Epidemiological studies in Greenland 1962-1964. I. Diabetes mellitus in Eskimos. Acta Med Scand 179:29-39, 1966
2. Kromann N, Green A: Epidemiological studies in the Upernavik District, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med Scand 208:401-406, 1980
3. Bang HO, Dyerberg J, Sinclair HM: The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 33:2657-2661, 1980
4. Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205-1209, 1985
5. Norell SE, Ahlbom A, Feychting M, Pedersen NL: Fish consumption and mortality from coronary heart disease. Br Med J 293:426, 1986
6. Feskens E, Bowles CH, Kromhout D: Inverse association between fish intake and risk of glucose intolerance in normoglycemic men and women. Diabetes Care 14:935-941, 1991
7. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
8. Malasanos TH, Stacpoole PW: Biological effects of omega-3 fatty acids in diabetes mellitus. Diabetes Care 14:1160-1179, 1991
9. Harris W: Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30:785-807, 1989
10. Nestel PJ: Effects of n-3 fatty acids on lipid metabolism, Ann Rev Nutr 10:149-167, 1990
11. Kasim SE: Dietary marine fish oils and insulin action in type 2 diabetes. Ann NY Acad Sci 683:250-257, 1993
12. Vessby B: Dietary supplementation with n- 3 polyunsaturated fatty acids in type 2 diabetes. Ann NY Acad Sci 683:244-249, 1993
13. Heine RJ: Dietary fish oil and insulin action, in humans. Ann NY Acad Sci 683:110-121, 1993
14. Fasching P, Ratheiser K, Waldhäusl W, Rohac M, Osterrode W, Nowotny P, Vier happer H: Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 40:583-589, 1991
15. Stacpoole PW, Alig J, Ammon L, Crockett SE: Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridaemia. Metabolism 38:946-956, 1989
16. Connor WE: Effects of omega-3 fatty acids in hypertriglyceridemic states. Semin Thromb Hemost 14:271-284, 1988
17. Sherertz EF: Improved acanthosis nigricans with lipodystrophic diabetes during dietary fish oil supplementation. Arch Dermatol 124:1094-1096, 1988
18. Lackey VA, Noble TA: Omega-3 fatty acid supplementation in noninsulin-dependent diabetes. DICP 24:258-260, 1990
19. Merrin PK, Elkeles RS: Treatment of diabetes: the effect on serum lipids and lipoproteins. Postgrad Med J 67:931-937, 1991
20. De Leeuw IH: Is there a place for n-3 fatty acids in the treatment of diabetic patients? Diabetes Nutr Metab 4:149-153, 1991
21. Bohannon NJV: Lipid metabolism in type II diabetes. Postgrad Med 92:105-106, 111-113, 1992
22. Fisher WR: Hypertriglyceridemia in diabetes: an approach to management. J Fla Med Assoc 78:747-507, 1991
23. Harris WS: Omega-3 fatty acids: effects on lipid metabolism. Curr Opin Lipidol 1:5-l l, 1990
24. Fish oils and diabetic microvascular disease (Editorial). Lancet 335:508-509, 1990
25. Popp-Snijders C, Bilo HJG, Heine RJ: Fish oil and glycemic control: importance of dose. Diabetes Care 13:80-81, 1990
26. Vessby B: N-3 fatty acids and blood glucose control in diabetes mellitus. J Intern Med 225 (Suppl.):207-210, 1989
27. Stamler J: Toward cardiovascular health. Ann Med 21:141-155, 1989
28. Stange EF: Atherosklerose bei diabetes mellitus. Internist (Berl) 30:297-303, 1989
29. Stacpoole PW, Alig J, Kilgore LL, Ayala CM, Herben PN, Zech LA, Fisher WR: Lipodystrophic diabetes mellitus: investigations of lipoprotein metabolism and the effect of omega-3 fatty acid administration in two patients. Metabolism 37:944-951, 1988
30. Garg A, Grundy SM: Treating dyslipidemia in patients with non-insulin-dependent diabetes mellitus. Cardiovasc Rev Report 9:30-36, 1988
31. Jensen T: Dietary supplementation with omega 3 fatty acids in insulin-dependent diabetes mellitus. World Rev Nutr Diet 66:417-424, 1991
32. Kissebah A, Schectman G: Polyunsaturated and saturated fat, cholesterol, and fatty acid supplementation. Diabetes Care 11:129- 142, 1988
33. Vessby B: Effects of omega 3 fatty acids on glucose and lipid metabolism in non- insulin-dependent diabetes mellitus. World Rev Nutr Diet 66:407-416, 1991
34. Landgraf-Leurs MMC, Drummer C, Fröschl H, Steinhuber R, von Schacky C, Landgraf R: Pilot study on omega-3 fatty acids in type I diabetes mellitus. Diabetes 39:369-375, 1990
35. Mon TA, Vandongen R, Maserei JRL, Dunbar D, Stanton KG: Serum lipids in insulin- dependent diabetics are markedly altered by dietary fish oils. Clin Exp Pharmacol Physiol 15:333-337, 1988
36. Vandongen R, Mon TA, Codde JP, Stanton KG, Masarei JR: Hypercholesterolaemic effect of fish oil in insulin-dependent diabetic patients. Med J Aust 148:141-143, 1988
37. Beitz J, Schimke E, Liebaug U, Block HU, Beitz A, Honigmann G, Sziegoleit W, Müller G, Mest HJ: Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxane. Klin Wochenschr 64:793-799, 1986
38. Tilvis RS, Rasi V, Viinikka L, Ylikorkala O, Miettinen TA: Effects of purified fish oil on platelet lipids and function in diabetic women. Clin Chim Acta 164:315-322, 1987
39. Pelikánová T, Kohout M, Válek J, Kazdová L, Baše J: Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients. Ann NY Acad Sci 683:272-278, 1993
40. Axelrod L, Camuso J, Williams E, Kleinman K, Briones E, Schoenfeld D: Effects of a small quantity of n-3 fatty acids on cardiovascular risk factors in NIDDM. Diabetes Care 17:37-44, 1994
41. Morgan WA, Raskin P, Rosenstock J: A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM. Diabetes Care 18:83-86, 1995
42. Heine RJ, Mulder C, Popp-Snijders C, van der Meer J, van der Veen EA: Linoleic-acid- enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in non-insulin- dependent diabetic patients. Am J Clin Nutr 49:448-456, 1989
43. De Leeuw IH, Van Gaal L, Rillaerts E, Dalemans C: Effects of the relative enrichment of polyunsaturated fatty acids in insulin- dependent diabetic patients. Diabete Metab 12:246-249, 1986
44. Jones DB, Haitas B, Bown EG, Carter RD, Barker K, Jelfs R, Turner RC, Mann JI, Prescott RJ: Platelet aggregation in non- insulin-dependent diabetes is associated with platelet fatty acids. Diabet Med 3:52-55, 1986
45. Andreani D, Di Mario U, Pozzili P: Prediction, prevention and early intervention in insulin-dependent diabetes, Diabetes Metab Rev 7:61-77, 1991
46. Wahlqvisi ML, Lo CS, Myers KA: Fish intake and arterial wall characteristics in healthy people and diabetic patients. Lancet ii:944-946, 1989
47. Raheja B, Bhakta V, Chandiramani A, Banavalikar S, Phatak R, Vispute K, Rao M: Use of fish oil locally in the management of diabetic foot: preliminary observations. J Diabet Assoc India 29:47-48, 1989
48. Gwynn CK, O'Neil KM: The effects of fish oil supplementation in a diabetic CAPD patient using intraperitoneal insulin. Dialysis Transplant 18:614-616, 1989
49. Hendra TJ, Britton ME, Roper DR, Wagaine-Twabwe D, Jeremy JY, Dandona P, Haines AR, Yudkin JS: Effects of fish oil supplements in NIDDM subjects: controlled study Diabetes Care 13:821-829, 1990
50. Westerveld HT, de Graaf JC, van Breugel HHFI, Akkerman JWN, Sixma JJ, Erkelens DW, Banga JD: Effects of low-dose epa-E on glycemic control, lipid profile, lipoprotein (a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 16:683-688, 1993
51. Mon TA, Vandongen R, Masarei JRL, Rouse IL, Dunbar D: Comparison of diets supplemented with fish oil or olive oil on plasma lipoproteins in insulin-dependent diabetics. Metabolism 40:241-246, 1991
52. Annuzzi G, Rivellese A, Capaldo B, Di Marino L, Iovine C, Marotta G, Riccardi G: Controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 87:65-73, 1991
53. Jensen T, Stender S, Goldstein K, Holmer G, Decken T: Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N Engl J Med 321:1552-1557, 1989
54. Vessby B, Boberg M: Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Int Med 228:165-171, 1990
55. Borkman M, Chisholm DJ, Furier SM, Storlien LH, Kraegen EW, Simons LA, Chesterman CN: Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38:1314-1319, 1989
56. Connor WE, Prince MJ, Ullmann D, Riddle M, Hatcher L, Smith FE, Wilson D. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann NY Acad Sci 683: 337-341, 1993
57. Haines AP, Sanders TAB, Imeson JD, Mahler RF, Martin J, Mistry M, Vickers M, Wallace PG: Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics. Thromb Res 43:643-655, 1986
58. Schectman G, Kaul S, Kissebah AH: Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 37:1567- 1573, 1988
59. Tariq T, Close C, Dodds R, Viberti GC, Lee T, Vergani D: The effects of fish-oil on the remission of type I (insulin-dependent) diabetes in newly diagnosed patients (Letter). Diabetologta 32:765, 1989
60. Mori TA, Vandongen R, Masarei JR: Fish oil-induced changes in apolipoproteins in IDDM subjects. Diabetes Care 13:725-732, 1990
61. Zambon S, Friday KE, Childs MT, Fujimoto WY, Bierman EL, Ensinck JW: Effect of glyburide and Ω3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 56:447-454, 1992
62. Spannagl M, Drummer C, Fröschl H, von Schacky C, Landgraf-Leurs MM, Landgraf R, Schramm W: Plasmatic factors of haemostasis remain essentially unchanged except for PAI activity during n-3 fatty acid intake in type I diabetes mellitus. Blood Coogul Fibrinolysis 2:259-265, 1991
63. Rillaerts EG, Engelmann GJ, Van Camp KM, De Leeuw I: Effect of omega-3 fatty acids in diet of type I diabetic subjects on lipid values and hemorheological parameters. Diabetes 38:1412-1416, 1989
64. Herrmann W, Biermann J, Ratzmann KP, Lindhofer HG: Zur Wirkung von Fischoelkonzentrat auf das Lipoproteinprofil bei Patienten mit Diabetes Mellitus Typ II. Med Klin 87:12-15, 1992
65. Friday KE, Childs MT, Tsunehara CH, Fujimoto WY, Bierman EL, Ensinck JW: Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes. Diabetes Can 12:276-281, 1989
66. Mon TA, Vandongen R, Masarei JR, Stanton KG, Dunbar D: Dietary fish oils increase serum lipids in insulin-dependent diabetics compared with healthy controls. Metabolism 38:404-409, 1989
67. Schmidt EB, Sorensen PJ, Pedersen JO, Jersild C, Ditzel J, Grunnet N, Dyerberg J: The effect of n-3 polyunsaturated fatty acids on lipids, haemostasis, neutrophil and monocyte chemotaxis in insulin-dependent diabetes mellitus. J Intern Med 225 (Suppl.):201-206, 1989
68. Schimke E, Hildebrandt R, Beitz J, Schimke I, Semmler S, Honigmann G, Mest HJ, Schliack V: Influence of a cod liver oil diet in diabetics type I on fatty acid patterns and platelet aggregation, Biomed Biochim Acta 43:5351-5353, 1984
69. Glauber H, Wallace P, Griver K, Brechtel G: Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108:663-668, 1988
70. Miller ME, Anagnostou AA, Ley B, Marshall P, Steiner M: Effect of fish oil concentrates on hemorheological and hemostatic aspects of diabetes mellitus: a preliminary study. Thromb Res 47:201-214, 1987
71. Popp-Snijders C, Scheuten JA, Heine RJ, van der Meer J, van der Veen EA: Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 4:141-147, 1987
72. Kasim SE, Stern B, Khilnani S, Mclin P, Baciorowski S, Jen KLC: Effects of omega- 3 fish oils on lipid metabolism, glycemic control and blood pressure in type II diabetic patients. J Clin Endocrinol Metab 67:1-5, 1988
73. Bagdade JD, Buchanan WE, Levy RA, Subbaiah PV, Ritter MC: Effects of Ω-3 fish oils on plasma lipids, lipoprotein compositions, and postheparin lipoprotein lipase in women with IDDM. Diabetes 39:426-431, 1990
74. Kamada T, Yamashita T, Baba Y, Kai M, Setoyama S, Chuman Y, Otsuji S: Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients. Diabetes 35:604-611, 1986
75. Mogadam M, Ahmed SW, Mensch AH, Godwin ID: Within-person fluctuations of serum cholesterol and lipoproteins. Arch Intern Med 150:1645-1648, 1990
76. Bookstein L, Gidding SS, Donovan M, Smith FA: Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Arch Intern Med 150:1653-1657, 1990
77. Sorisky A, Robbins DC: Fish oil and diabetes (Editorial). Diabetes Care 12:302- 304, 1989
78. Axelrod L: Omega-3 fatty acids in diabetes mellitus. Diabetes 38:539-543, 1989
79. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R: Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 74:82-89, 1984
80. Harris WS, Connor WE, Illingworth R, Rothrock DW, Foster DM: Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 31:1549-1558, 1990
81. Huff MW, Telford DE: Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein. Arterioscler Thromb Vasc Biol 9:58-66, 1989
82. Lindsey S, Pronczuk A, Hayes KC: Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells. J Lipid Res 33:647-658, 1992
83. Linga V, Leight MA, Curtiss LK, Marcel YL, St Clair RV, Parks JS: Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblast is mediated by apoliprotein E. J Lipid Res 35:491-500, 1994
84. Puhakainen I, Ahola I, Yki-Järvinen H: Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 61:121-126, 1995
85. Willumsen N, Skorve J, Hexeberg S, Rustan AC, Berge RK: The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis. Lipids 28:683-690, 1993
86. Froyland L, Vaagenes H, Asiedu DK, Garras A, Lie O, Berge RK: Chronic administration of eicosapentaenoic acid and docosa- hexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs. Lipids 31:169-178, 1996
87. Rambjor GS, Walen AI, Windsor SL, Harris WS: Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect offish oil. Lipids 31:S45-S49, 1996
88. Willumsen N, Hexeberg S, Skorve J, Lundquist M, Berge RK: Docosahexaenoic acid shows no triglyceride-lowering effects in rats but increases the peroxismal fatty acid oxidation in liver of rats. J Lipid Res 34:13-22, 1993
89. American Diabetes Association: Detection and management of lipid disorders in diabetes (Consensus Statement). Diabetes Care 19 (Suppl. 1):S96-S102, 1996
90. Taskinen MR: Hyperlipidaemia in diabetes. Bailliere's Clin Endocrinol Metab 4:743-775, 1990
91. Pierce LR, Wysowski DK, Gross TP: Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 264:71-75, 1990
92. Contacos C, Barter PHJ, Sullivan DR: Effect of pravastatin and Ω3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arteriosder Thromb Vasc Biol 13:1755-1762, 1993